Search results for: 'm13e fuels develop deceleration'
- Related search terms
- development startup and future trend of ophthalmic drugs market
- development states and future trend of ophthalmic drugs market
- m13e based system engineering market
- development startup ad future trend of ophthalmic drugs market
- m13e notification system services market
-
23 Aug 2010  |  North America  |  Market Research
Vital Signs - Biomarkers for Improved and Accelerated Sepsis Treatment: Enabling Clinicians to Definitively Diagnose the Disease, Identify the Causative Agent, and Determine the Appropriate Type and Dosage of Antibiotic
This issue of Vital Signs, released on August 23, 2010, provides a strategic analysis of trends in biomarkers for improved and accelerated sepsis treatment. Additionally, a company spotlight is provided for BRAHMS, a global biotechnology company committed to improving healthcare through the discovery and development of novel and innovative bio...
$1,500.00
Special Price $1,125.00 save 25 %